Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Tenchusatsu who wrote (1341263)	2/4/2022 9:14:58 PM
From: h_	3 Recommendations Recommended By isopatch roguedolphin Winfastorlose Respond to of 1573123

Page 14 • Animal testing was skipped • Phases II/III were combined • After 2 months of Phase II/III, Emergency Use Authorized • The trials were unblinded • Phase III trials are ongoing until 2023

To: Tenchusatsu who wrote (1341263)	2/4/2022 9:15:59 PM
From: h_	Respond to of 1573123

Page 15 When designing a trial for the efficacy and safety of a potential treatment, the focus should be on the target population who could most benefit from that treatment. Instead Pfizer chose participants from younger demographic that would be a) less likely to need a vaccine, b) less likely to suffer an adverse event during a trial, c) more likely to respond well to a vaccine, as the elderly have comparatively poor immune responses.

To: Tenchusatsu who wrote (1341263)	2/4/2022 9:17:15 PM
From: h_	2 Recommendations Recommended By isopatch roguedolphin Respond to of 1573123

Page 16 • We are told the inoculations are “safe.” Yet many health conditions - in fact a list several pages long - were excluded from the trials, including pregnant or breastfeeding women, people with allergies, with psychiatric conditions, immunocompromised people, people with bleeding disorders, people who had previously tested positive for COVID-19, people who had been prescribed steroids, etc., so there has never been any data to make safety claims about those people. Yet they are also not excluded from mandates and vaccine passports. • The vaccines were tested on the healthy, and then immediately given to the frailest members of the society - the elderly with multiple health conditions. This is unscientific and unethical.

To: Tenchusatsu who wrote (1341263)	2/4/2022 9:19:06 PM
From: h_	2 Recommendations Recommended By isopatch roguedolphin Respond to of 1573123

Page 18 High quality safety science would have meant they should have tested before & after inoculation for: • d-dimers for evidence of enhanced coagulation/clotting (several of our doctors have noticed increased levels of d-dimers in inoculated patients presenting with stroke like symptoms - video available here) • C-reactive protein for evidence of enhanced inflammation • troponins for evidence of cardiac damage • occludin and claudin for evidence of enhanced barrier permeability • blood oxygen levels for evidence of enhanced hypoxia • amyloid-beta and phosphorylated tau for evidence of increased predisposition to Alzheimer’s disease • Serum HMGB1, CXCL13, Dickkopf-1 for evidence of an increased disposition to autoimmune disease, etc.